Search - tctmd.com

Displaying 801 - 820 of 2566

Sort: Relevancy | Date

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

Hormone Therapy Ups CV Risk in Transgender Individuals

Caitlin E. Cox

February 18, 2019

Presentation JIM 2019

Stent under-expansion: tips & tricks

Presenter: Jacopo Oreglia

February 13, 2019

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Caitlin E. Cox

February 08, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

Manuscript

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

February 06, 2019

News Conference News ISET 2019

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Caitlin E. Cox

January 30, 2019

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Yael L. Maxwell

January 14, 2019

News Daily News

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

Todd Neale

January 14, 2019

News Daily News

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

L.A. McKeown

January 14, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

L.A. McKeown

December 07, 2018

News Daily News

US and European DAPT Guidelines More Alike Than Different, Say Experts

Yael L. Maxwell

December 03, 2018

News Daily News

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

Caitlin E. Cox

November 28, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

Advertisement

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Hormone Therapy Ups CV Risk in Transgender Individuals

Stent under-expansion: tips & tricks

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Top News in Coronary Artery Disease: 2018

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

US and European DAPT Guidelines More Alike Than Different, Say Experts

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content